Sponsored
Sponsored
Media Summary: PCRI's Executive Director, Mark Scholz, MD, talks about stereotactic body radiation therapy ( Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Michael J. Zelefsky, MD, explores outcomes for prostate brachytherapy vs. EBRT vs.

Sbrt For The Intermediate Risk - Detailed Analysis & Overview

PCRI's Executive Director, Mark Scholz, MD, talks about stereotactic body radiation therapy ( Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Michael J. Zelefsky, MD, explores outcomes for prostate brachytherapy vs. EBRT vs. Join Dr. Art Rastinehad in this enlightening session tailored for patients facing unfavorable PCRI's Executive Director, Mark Scholz, MD, explains a clinical trial (NCT03367702) for men with High-Sky and Low to Basic-Teal ... In this episode of BackTable Urology, Dr. Aditya Bagrodia discusses radiation therapy for favorable

PCRI's Executive Director, Mark Scholz, MD, compares different treatments for men with Teal stage ( MUSC Hollings Cancer Center radiation oncologist Dr. David Marshall reviews the treatment options for At the ESTRO 2025 Congress, Prof. Andrew Loblaw from the University of Toronto presented a comparative analysis of Dov Kadmon, MD, Professor of Urology at Baylor College of Medicine in Houston, Texas, provides a comprehensive overview of ... David T. Marshall, M.D., is a board-certified radiation oncologist, specializing in genitourinary and gastrointestinal cancers at ... Filmed in February 2020 Backed by extensive clinical evidence, the Decipher® Prostate Genomic Classifier helps clinicians and ...

This video will discuss the the success rate and the side effects with Cyberknife and surgery for unfavorable PCRI's Alex asks Dr. Scholz questions from our YouTube comments on the side effects of hormone therapy, whether it is ... There are many treatments for prostate cancer and one of them is radiation therapy. Within radiation therapy, there are all sorts of ... In this video, medical oncologist Dr. Mark Scholz compares two radiation therapy techniques: Intensity-Modulated Radiation ... PCRI's Executive Director, Mark Scholz, MD, talks about hormone therapy (TIP) as a standalone treatment for men with the Teal ... Christopher J. Kane, MD, FACS, the Dean of Clinical Affairs at the University of California San Diego School of Medicine, and the ...

Giulio Francolini, MD, University of Florence, Florence, Italy, provides an overview of the ULTRA-HERO trial design, a prospective ...

Photo Gallery

SBRT for the Intermediate-Risk (Teal)  Prostate Cancer | Prostate Cancer Staging Guide
Intermediate-Risk: Do You Need Hormone Therapy With Radiation? | #MarkScholzMD #AlexScholz #PCRI
Comparative Outcomes: Prostate Brachytherapy vs. EBRT vs. SBRT for Low/Intermediate Risk Disease
Managing Unfavorable Intermediate Risk Prostate Cancer: Expert Guidance with Dr. Art Rastinehad
Clinical Trial: SBRT vs IMRT For Low Risk to Intermediate-Risk Prostate Cancer | PCRI
Radiation Therapy for Favorable Intermediate Risk Prostate Cancer w/ Dr. Amar Kishan | Ep. 53
Choosing a Treatment for Intermediate Risk Prostate Cancer | Prostate Cancer Staging Guide
Intermediate Risk Prostate Cancer
Andrew Loblaw on SBRT vs Brachytherapy in Prostate Cancer | ESTRO 2025
Counseling Men with Favorable Intermediate Risk Prostate Cancer: How to Advise? by Dov Kadmon, MD
Intermediate risk prostate cancer
Intermediate-Risk Prostate Cancer Treatment - MUSC Hollings
View Detailed Profile
SBRT for the Intermediate-Risk (Teal)  Prostate Cancer | Prostate Cancer Staging Guide

SBRT for the Intermediate-Risk (Teal) Prostate Cancer | Prostate Cancer Staging Guide

PCRI's Executive Director, Mark Scholz, MD, talks about stereotactic body radiation therapy (

Intermediate-Risk: Do You Need Hormone Therapy With Radiation? | #MarkScholzMD #AlexScholz #PCRI

Intermediate-Risk: Do You Need Hormone Therapy With Radiation? | #MarkScholzMD #AlexScholz #PCRI

Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for

Sponsored
Comparative Outcomes: Prostate Brachytherapy vs. EBRT vs. SBRT for Low/Intermediate Risk Disease

Comparative Outcomes: Prostate Brachytherapy vs. EBRT vs. SBRT for Low/Intermediate Risk Disease

Michael J. Zelefsky, MD, explores outcomes for prostate brachytherapy vs. EBRT vs.

Managing Unfavorable Intermediate Risk Prostate Cancer: Expert Guidance with Dr. Art Rastinehad

Managing Unfavorable Intermediate Risk Prostate Cancer: Expert Guidance with Dr. Art Rastinehad

Join Dr. Art Rastinehad in this enlightening session tailored for patients facing unfavorable

Clinical Trial: SBRT vs IMRT For Low Risk to Intermediate-Risk Prostate Cancer | PCRI

Clinical Trial: SBRT vs IMRT For Low Risk to Intermediate-Risk Prostate Cancer | PCRI

PCRI's Executive Director, Mark Scholz, MD, explains a clinical trial (NCT03367702) for men with High-Sky and Low to Basic-Teal ...

Sponsored
Radiation Therapy for Favorable Intermediate Risk Prostate Cancer w/ Dr. Amar Kishan | Ep. 53

Radiation Therapy for Favorable Intermediate Risk Prostate Cancer w/ Dr. Amar Kishan | Ep. 53

In this episode of BackTable Urology, Dr. Aditya Bagrodia discusses radiation therapy for favorable

Choosing a Treatment for Intermediate Risk Prostate Cancer | Prostate Cancer Staging Guide

Choosing a Treatment for Intermediate Risk Prostate Cancer | Prostate Cancer Staging Guide

PCRI's Executive Director, Mark Scholz, MD, compares different treatments for men with Teal stage (

Intermediate Risk Prostate Cancer

Intermediate Risk Prostate Cancer

MUSC Hollings Cancer Center radiation oncologist Dr. David Marshall reviews the treatment options for

Andrew Loblaw on SBRT vs Brachytherapy in Prostate Cancer | ESTRO 2025

Andrew Loblaw on SBRT vs Brachytherapy in Prostate Cancer | ESTRO 2025

At the ESTRO 2025 Congress, Prof. Andrew Loblaw from the University of Toronto presented a comparative analysis of

Counseling Men with Favorable Intermediate Risk Prostate Cancer: How to Advise? by Dov Kadmon, MD

Counseling Men with Favorable Intermediate Risk Prostate Cancer: How to Advise? by Dov Kadmon, MD

Dov Kadmon, MD, Professor of Urology at Baylor College of Medicine in Houston, Texas, provides a comprehensive overview of ...

Intermediate risk prostate cancer

Intermediate risk prostate cancer

Intermediate

Intermediate-Risk Prostate Cancer Treatment - MUSC Hollings

Intermediate-Risk Prostate Cancer Treatment - MUSC Hollings

David T. Marshall, M.D., is a board-certified radiation oncologist, specializing in genitourinary and gastrointestinal cancers at ...

Decipher Prostate | Intermediate Risk Prostate Cancer

Decipher Prostate | Intermediate Risk Prostate Cancer

Filmed in February 2020 Backed by extensive clinical evidence, the Decipher® Prostate Genomic Classifier helps clinicians and ...

Which Treatment is Better for Unfavorable Intermediate Risk Prostate Cancer, Cyberknife or surgery?

Which Treatment is Better for Unfavorable Intermediate Risk Prostate Cancer, Cyberknife or surgery?

This video will discuss the the success rate and the side effects with Cyberknife and surgery for unfavorable

Determining How Aggressively to Treat Relapsed & Intermediate-Risk Prostate Cancer | Mark Scholz, MD

Determining How Aggressively to Treat Relapsed & Intermediate-Risk Prostate Cancer | Mark Scholz, MD

PCRI's Alex asks Dr. Scholz questions from our YouTube comments on the side effects of hormone therapy, whether it is ...

Ep. 22 - Is SBRT (Cyberknife) a Good Treatment for Prostate Cancer?

Ep. 22 - Is SBRT (Cyberknife) a Good Treatment for Prostate Cancer?

There are many treatments for prostate cancer and one of them is radiation therapy. Within radiation therapy, there are all sorts of ...

IMRT vs. SBRT & Reducing Radiation Toxicity | #MarkScholzMD #AlexScholz #PCRI

IMRT vs. SBRT & Reducing Radiation Toxicity | #MarkScholzMD #AlexScholz #PCRI

In this video, medical oncologist Dr. Mark Scholz compares two radiation therapy techniques: Intensity-Modulated Radiation ...

Hormone Therapy for Intermediate-Risk (Teal) Prostate Cancer | Prostate Cancer Staging Guide

Hormone Therapy for Intermediate-Risk (Teal) Prostate Cancer | Prostate Cancer Staging Guide

PCRI's Executive Director, Mark Scholz, MD, talks about hormone therapy (TIP) as a standalone treatment for men with the Teal ...

Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer - Surgery

Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer - Surgery

Christopher J. Kane, MD, FACS, the Dean of Clinical Affairs at the University of California San Diego School of Medicine, and the ...

ULTRA-HERO: radiotherapy & relugolix for intermediate risk prostate cancer

ULTRA-HERO: radiotherapy & relugolix for intermediate risk prostate cancer

Giulio Francolini, MD, University of Florence, Florence, Italy, provides an overview of the ULTRA-HERO trial design, a prospective ...

Related Video Content

Stereotactic body radiotherapy - Mayo Clinic information

Feb 6, 2026 · Stereotactic body radiotherapy (SBRT) is a type of noninvasive treatment that uses precisely focused...

What Is Stereotactic Body Radiation Therapy (SBRT)? information

Stereotactic body radiation therapy, or SBRT, is a cancer treatment that delivers extremely precise, very intense...

Stereotactic Body Radiation Therapy (SBRT) - Cleveland Clinic information

Jun 19, 2024 · Stereotactic body radiation therapy (SBRT) targets small tumors with large radiation doses without...

What is Stereotactic Body Radiation Therapy (SBRT)? Know Before ... information

Stereotactic body radiation therapy (SBRT) precisely targets tumors with very high doses of radiation. It is also...

Stereotactic Body Radiotherapy (SBRT) Side Effects and More information

Feb 23, 2026 · SBRT is often used for small, inoperable early-stage lung cancers. Tumor size and location affect...

Sponsored